CIK 0001133416 · Non-accelerated filer<br>Smaller reporting company
GALECTIN THERAPEUTICS INC
Sign in to watch- Ticker
- GALT
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- operating
- EIN
- 043562325
- Phone
- 678-620-3186
- Business address
- 4960 PEACHTREE INDUSTRIAL BOULEVARD, SUITE 240, NORCROSS, GA, 30071
- Former names
- PRO PHARMACEUTICALS INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-31 | Uihlein Richard E Director | Option exercise | +31,825,235 | $3.00 | $95.5M | 42,162,911 |
| 2026-07-31 | Uihlein Richard E Director | Option exercise | +2,550,932 | $4.05 | $10.3M | 44,713,843 |
| 2026-07-31 | Uihlein Richard E Director | Option exercise · Line of Credit Convertible Notes | −0 | $95,475,705.00 | $0 | 0 |
| 2026-07-31 | Uihlein Richard E Director | Option exercise · Line of Credit Convertible Notes | −0 | $10,331,275.00 | $0 | 0 |
| 2026-07-14 | Jamil Khurram Chief Medical Officer | Option exercise 10b5-1 | +16,250 | $3.04 | $49K | 16,250 |
| 2026-07-14 | Jamil Khurram Chief Medical Officer | Sale 10b5-1 | −16,250 | $5.13 | $83K | 0 |
| 2026-07-14 | Jamil Khurram Chief Medical Officer | Option exercise · Stock option (right to buy) 10b5-1 | −16,250 | 48,750 | ||
| 2026-06-29 | Shlevin Harold H. Director | Option exercise 10b5-1 | +22,268 | $1.23 | $27K | 28,768 |
| 2026-06-29 | Shlevin Harold H. Director | Sale 10b5-1 | −22,268 | $5.04 | $112K | 6,500 |
| 2026-06-29 | Shlevin Harold H. Director | Option exercise · Stock Option (right to buy) 10b5-1 | −22,268 | 30,000 | ||
| 2026-06-29 | Jamil Khurram Chief Medical Officer | Option exercise 10b5-1 | +47,467 | $2.50 | $119K | 47,467 |
| 2026-06-29 | Jamil Khurram Chief Medical Officer | Sale 10b5-1 | −47,467 | $5.04 | $239K | 0 |
| 2026-06-29 | Jamil Khurram Chief Medical Officer | Option exercise · Stock Option (right to buy) 10b5-1 | −47,467 | 0 | ||
| 2026-06-26 | Shlevin Harold H. Director | Option exercise 10b5-1 | +7,732 | $1.23 | $10K | 14,232 |
| 2026-06-26 | Shlevin Harold H. Director | Sale 10b5-1 | −7,732 | $5.00 | $39K | 6,500 |
| 2026-06-26 | Shlevin Harold H. Director | Option exercise · Stock Option (right to buy) 10b5-1 | −7,732 | 52,268 | ||
| 2026-06-26 | Jamil Khurram Chief Medical Officer | Option exercise 10b5-1 | +2,037 | $2.20 | $4K | 2,037 |
| 2026-06-26 | Jamil Khurram Chief Medical Officer | Sale 10b5-1 | −2,037 | $5.00 | $10K | 0 |
| 2026-06-26 | Jamil Khurram Chief Medical Officer | Option exercise 10b5-1 | +2,533 | $2.50 | $6K | 2,533 |
| 2026-06-26 | Jamil Khurram Chief Medical Officer | Sale 10b5-1 | −2,533 | $5.00 | $13K | 0 |
Page 1 of 15 · 291 trades